(15-30ml/min) 3 . Serum Creatinine screening has been used as a tool to identify individuals who are at increased risk of developing future kidney disease or impaired renal function. It is well known to everyone that high serum Creatinine and low Creatinine clearance contribute to renal function loss 4 . Although, this approach has been useful, it fails to identify almost half of the individuals with mildly increased serum Creatinine who develop chronic renal failure each year. So, other laboratory tests, although less well known, can also help to predict renovascular diseases. These additional assays are related to chronic inflammation 4, 5 .
HS CRP is the acute phase protein, which is produced by liver. It has been used for many years as a very sensitive marker of systemic inflammation. Normally its circulatory level is low but infection, inflammation or tissue injury induces a marked increase in hepatic synthesis of HS CRP and may exceed 300mg/l with in 48 hours of an acute event.
High levels may persist in chronic inflammatory status 5 . HS CRP production is mediated by several inflammatory mediators like interlewkin-6 (IL-6). CRP and IL-6 both are elevated in chronic renal failure patients 6 . Stuveling et al., in 2003 had done a prospective study regarding the association of HS CRP with renal function abnormalities in a large non diabetic population. They found positive correlation between renal function loss & elevated C-reactive protein level. They found an inverse relationship in between HS CRP and creatinine clearance 7 .
Patients and Methods
This case control study of serum HS CRP and blood urea, serum creatinine and creatinine clearance in CRF patients was carried out in the Department of Biochemistry, Dhaka Medical College, Dhaka during the period of July 2004 to July 2005. 50 diagnosed chronic renal failure patients of both sexes yet not treated by dialysis and 50 age and sex matched healthy subjects were included in the study as case (Group-1I) and control (Group-I) respectively. Patients having age more than 45 years, smoker, alcoholics, severe skeletal muscle disease, history of trauma, diabetics, and hypertensive were excluded from the study. After having deliberate conscent from patient, data was collected and 5ml venous blood was drawn aseptically. Then the blood immediately transferred to a dry clean test tube and allowed to clot. The sample was then centrifuged and serum was collected in an ependrop tube appropriately and then labeled and preserved at -20°C in a refrigerator before estimation. Random blood glucose was first estimated with the sample to exclude the diabetic subjects. HS CRP, urea, creatinine and creatinine clearance were then estimated in the preserved sample. HS CRP measured by immunonephelometric method, and blood urea, serum creatinine measured by enzymatic colorimetric method and creatinine clearance by Cockcorf formula to find out the significance. Data were analyzed by using SPSS software. Mean values of the different parameter were compared by 'Mann Whiteny U' test and 'r' test to see the level of significance. 95% confidence limit (p<0.0005) was taken as level of significance.
Results:
Total 100 subjects of both sexes were grouped as Group-I (50 control) and Group-II (50 case). Table IV and figure-2 show the high negative significant correlation between HS CRP and creatinine clearance. 
Discussion:
In this case control study we have measured the serum HS CRP, serum urea, serum creatinine and creatinnne clearance. Mean serum HS CRP concentration found in Group-II (CRF) was 50.938±38.88 mg/l and ranges from 2.4-125 mg/l. Chronic renal failure (Group-II) patients of this study has shown serum HS CRP concentration significantly higher in comparison to control (Group-I) 8, 9 . In Group-IIA, Group-IIB and Group-II C mean serum HS CRP concentration has been found that 6.83 ±2.49, 51.18± 15.87 and 94.82±16.54mg/l respectively. That is serum HS CRP concentration increases according to severity of renal failure. Same phenomenon observed in many other studies around the world 10 .
The present study searched for a correlation between HS CRP and creatinine clearance and found a negative correlation between HS CRP and creatinine clearance and a positive correlation co-efficient in between HS CRP and creatinine and urea where r= .937 and .783 respectively. In the present study a comparison has been done between creatinine clearance and serum creatinine. Figure-1 shows that serum creatinine does not increase at a significantly higher level until the serum creatinine clearance has been grossly reduced. So it can be suggested that in early failure serum creatinine is not sufficient to indicate the renal function loss. Whereas Figure- 2 of this study shows a comparison between CCR and HS CRP. Where decreased renal function loss from the very beginning is reflected by increase in HS CRP. This observation suggests that in early renal failure HS CRP along with CCR can be good markers of CRF than creatinine clearance alone. This findings is in consistent with other studies 11 .
The statistical analysis of the present study shows that serum HS CRP is significantly higher than control and the increased concentration is directly proportional to the severity of renal function loss where serum urea, creatinine and creatinine clearance are markers of the severity. This study also shows that in early CRF HS CRP is a better marker of renal function loss than creatinine clearance alone. This finding is in consistent with other's findings 12 .
From this study, we can suggest that HS CRP should be done with the other parameters in CRF patients for early diagnosis in the irreversible stage so that further progression of the disease can be arrested.
Above findings tend to support that HS CRP is a good stable marker predictor of Chronic renal failure despite the fact that it is an acute phase reactant. It also supports the measurements of serum HS CRP along with serum urea, creatinine and creatinine clearance to predict future chronic renal failure in a more dependable and authentic manner.
